Skip to content
PharmaManufacturingIQ

Micreos’ chief medical officer talks to EPM about antibiotic alternatives

Johan Frieling has recently been appointed as the new chief medical officer of Micreos. EPM talks to him about his experience in the pharmaceutical sector and the company’s new antibiotic alternative, Staphefekt

By PharmaManufacturing IQ Staff
Micreos’ chief medical officer talks to EPM about antibiotic alternatives
Published: | 2 min read
Share to X Share to Bluesky Share to Facebook Share to LinkedIn Share by email

Johan Frieling has recently been appointed as the new chief medical officer of Micreos. EPM talks to him about his experience in the pharmaceutical sector and the company’s new antibiotic alternative, Staphefekt

Johan Frieling, chief medical officer, Micreos

Sign up to our newsletter

The week's biggest stories from this industry, direct to your inbox.

Personal information